États-Unis · Bourse & Finance · MarketWatch

Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi

Publié par MarketWatch · États-Unis il y a 12 h

Alvotech shares rose after the company said the Food and Drug Administration has approved a supplement to the biologics license application for AVT02 adalimumab-ryvk, marketed in…

Lire l'article complet sur MarketWatch Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketwatch.com)

Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi

À lire aussi

AstraZeneca CEO Soriot says drugmaker can grow without big acquisition

Texas businessman gets 13 years in federal prison as feds seize his Lamborghinis, Ferraris, Firebird and dozens more cars to pay back fraud victims

These are the longest rivers on every continent

Singapore Eyes Nuclear Power as Iran War Exposes Its Import Problem

FinCEN withdraws proposed crypto mixing rule over ‘legitimate activity’ concerns

OpenAI will start watermarking ChatGPT’s text in the EU

Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi

Partager

À lire aussi

AstraZeneca CEO Soriot says drugmaker can grow without big acquisition

Texas businessman gets 13 years in federal prison as feds seize his Lamborghinis, Ferraris, Firebird and dozens more cars to pay back fraud victims

These are the longest rivers on every continent

Singapore Eyes Nuclear Power as Iran War Exposes Its Import Problem

FinCEN withdraws proposed crypto mixing rule over ‘legitimate activity’ concerns

OpenAI will start watermarking ChatGPT’s text in the EU